h1

navindexsubmissionagendafacultyprogramlakeregistrationnav

title

Thursday, September 13


3:00 PM                Registration

4:00 - 4:30            Welcome and Overview of Program

Kenneth Sherman, MD, PhD - University of Cincinnati

Session 1            Epidemiology and Scope of Disease
                             Moderator: Henry Masur, MD - NIH

4:30 – 5:00            HIV Transmission and Care Cascade 2018

John Brooks, MD - Centers for Disease Control and Prevention

5:00 – 5:30            HIV Treatment in 2018: When to Start, What to Start

Rajesh Tim Gandhi, MD - Harvard Medical School, Massachusetts General Hospital

5:30 – 6:00            ESLD and HCC in HIV-Infected Persons - Epidemiology

Vincent Lo Re, MD, MSCE - University of Pennsylvania, Perelman School of Medicine

6:00 – 6:30            Aging of the Liver: What this Means for Patients with HIV 

Steven Choi, MD - Duke University School of Medicine

6:30 – 6:45            Selected Abstract 

Hepatitis A Seropositivity Among HIV-Negative and Newly HIV-Diagnosed Men who have Sex with Men (MSM) in San Diego

Thomas Martin, MD, MS - University of California San Diego

6:45 - 7:00             PANEL DISCUSSION 

7:00 – 9:00            Poster Reception (all poster presenters at posters), Cocktail Reception

Friday, September 14


7:30 - 8:00 AM      Continental Breakfast

Session 2             Pathophysiology and Immunobiology of Liver Disease in HIV-Infected Patients 
                              
Moderator:  David Thomas, MD, PhD - Johns Hopkins University School of Medicine

8:00 - 8:30             Mechanisms of Liver Injury Relevant to the HIV-infected Patient

Raymond T. Chung, MD - Massachusetts General Hospital, Harvard Medical School

8:30 - 9:00             Role of CCR5 and CCR2 in Liver Disease

Shyamasundaran Kottilil, MBBS, PhD - University of Maryland, School of Medicine

             9:00 – 9:30           The Microbiome in HIV 

Robert D. Burk, MD - Albert Einstein College of Medicine

9:30 - 9:45            Selected Abstract    
                              

                                        High Kynurenine-Tryptophan Ratio is Associated with Fibrosis in HIV-Monoinfected
                                        and HIV/Hepatitis C Virus-Coinfected Women

                                        Ani Kardashian, MD - University of California Los Angeles

9:45 - 10:00          PANEL DISCUSSION
                             
                          
10:00 - 10:30          Break
 

Session 3            Hepatitis B and HIV
                             Moderator: Kenneth E. Sherman, MD, PhD - University of Cincinnati


10:30 – 11:00        New Targets for HBV Treatment

Marion Peters, MD - University of California, San Francisco

11:00 – 11:30        Solid Organ Transplantation in the Setting of HIV

Peter G. Stock, MD, PhD - University of California, San Francisco

11:30 - 12:00         HDV in HIV: Could/Should we Screen? If So, What Then?

Jeffrey S. Glenn, MD, PhD - Stanford University School of Medicine

12:00 – 12:30       Hepatitis B Vaccination in HIV-Infected Persons: Managing Failure

                                        Kenneth E. Sherman, MD, PhD - University of Cincinnati

12:30 – 12:45      Selected Abstract 

Temporal Trends in Liver Transplant (LT) for Viral and non-Viral Liver Diseases in Patients with Human Immunodeficiency Virus (HIV)

Jennifer Price, MD - University of California, San Francisco (on behalf of Isabel Campos Varela, MD - University of Santiago de Compostela)

12:45 – 1:00        Selected Abstract 

                              Molecular Epidemiological Evidence of Tibetan Migration to India for High HBV  
                                        Seroprevalence

Ameer Abutaleb, MD - University of Maryland

1:00 – 1:05          Move to Small Group Area

                                    

1:05 – 2:00          Small Group Case-based Lunches with Experts (Groups of 10 or less meet in private dining)

Saturday, September 15


7:30 - 8:00 AM      Continental Breakfast

Session 4            Hepatitis C and HIV
                             Moderator: Russell Fleischer, PA-C, MPH - U.S. Food and Drug Administration

8:00 - 8:30             Treatment of HCV/HIV Coinfected Patient

 David L. Wyles, MD - Denver Health, University of Colorado School of Medicine

             8:30 - 9:00            Complex Drug Interactions with HCV DAAs

                                                      Jennifer Kiser, PharmD, - University of Colorado Denver

9:00 - 9:30            HCV Elimination in HIV-Infected Patients  

 David Thomas, MD, MPH - Johns Hopkins University School of Medicine

9:30 - 9:45             PANEL DISCUSSION 
 

9:45 - 10:00          Break

Session 5             NAFLD and NASH in HIV
                              Moderator: Marion Peters, MD - University of California San Francisco

10:00 - 10:25        Diagnosis and Epidemiology of NAFLD/NASH in HIV

Richard Sterling, MD - NAFLD/NASH

10:25 - 10:50        New Treatments for NAFLD/NASH

Kathleen E. Corey, MD, MPH - Massachusetts General Hospital, Harvard Medical School

Session 6             Drugs and Alcohol in HIV and Hepatitis CoInfections
                              Moderator: Jag H. Khalsa, MS, PhD - Special Volunteer at NIDA/NIH

10:50 - 11:15         Unhealthy alcohol use among Patients with HIV: Reversing the Trends

E. Jennifer Edelman, MD, MHS - Yale School of Medicine

11:15 - 11:35          Acute and Chronic HCV - Harm Reduction/Prevention and Treatment in the Setting of Substance Abuse

Arthur Yu-Shin Kim, MD - Massachusetts General Hospital

11:35 - 11:55           Is Cocaine Use Associated with Liver Fibrosis?

                              Marianna K Baum, PhD - Florida International University

11:55 - 12:15           Modeling Harm Interventions to Prevent HCV and HIV Transmission

                              Natasha Martin, DPhil - University of California San Diego

12:15 - 12:40           Psychiatric Comorbidities in HIV - How it Affects Treatment of HIV and Hepatitis

                              Glenn Treisman, MD, PhD - Johns Hopkins University

Session 7            Research Agenda - Plans for the Next Two Years
                             Moderator: Kenneth E. Sherman, MD, PhD - University of Cincinnati

12:40 - 1:00           NIH Goals and Opportunities

                            Christine Chiou, MD - National Institute of Allergy and Infectious Diseases

1:00 - 1:20             Summary of Key Research Agenda Items

                                     Kenneth E. Sherman, MD, PhD - University of Cincinnati

 1:20 - 1:45              Conference Wrap-Up

                            Kenneth E. Sherman, MD, PhD - University of Cincinnati

Sponsored by University of Cincinnati
mer

Important Dates:

Registration - Now Open!
Abstract Submission Deadline - CLOSED
Housing Deadline - August 8

Faculty
Chair                                  
Kenneth E. Sherman, MD, PhD
Director, Division of Digestive Diseases
University of Cincinnati College of Medicine
Cincinnati, Ohio

Organizing Committee  
Marion Peters, MD
Chief of Hepatology Research
University of California San Francisco
San Francisco, California 

David Thomas, MD, MPH
Chief, Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland